Sunpure receives the patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®)

New Delhi (India), August 22: Sunpure announced a milestone in its ongoing intellectual property mission.  Sunpure has received a grant of Patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®) with enhanced Bioavailable Penta Active Components of Turmeric.

“We are thrilled to receive this patent, which highlights our commitment to innovation.  This patent (CURCUBOOST®) grant is a significant milestone for Sunpure Research Incubation Centre (SRIC), Sunpure Extracts Private Limited, and we look forward to bringing more such innovative health solutions and ingredients to our customers”, says Mr. Amit Srivastava (GM), Sunpure.

The application of Invention of Curcumin C5 AKTIV complex – CURCUBOOST® was accepted in 2019 and after addressing various queries it was granted in 2024. This patent will be in force till 2039.

The present invention envisioned chemical composition modification of the active molecules of Turmeric to make use of Curcuminoids with better Bioavailability and increased efficacy by using two more additional ingredients Turmerone and Polysaccharides of Turmeric along with Curcuminoids, says Mr. Singh, Principal Scientist, SRIC (Sunpure Research Incubation Centre).

SRIC scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe. This grant of patent is recognition of the pioneering work accomplished in the IP domain by the SEPL Team.

This shall bring economic benefit to formulators as by using less quantity of CURCUBOOST higher bioavailability can be attained and enhanced absorption shall lead to better efficacy.

“With its seamless application across various delivery mechanisms, this achievement reaffirms our dedication to pioneering technological integration of Ayurveda and modern science that redefine novel solutions. Our initiatives showcase our proactive commitment to environmental sustainability with use of whole biomass”, says Mr. Saurabh Sharma (VP), Sunpure.

Award is the recognition and celebration of Sunpure’s IP portfolio which has embraced IP generation and protection to fuel their economic growth and lend a hand towards the country’s economic progress.

Sunpure has GMP certification and an Ayurvedic license from AYUSH.

About Sunpure Extracts Private Limited (SEPL)

Sunpure Extracts Private Limited (SEPL) has natural extract production facilities in UP and Uttarakhand and exports natural ingredients to over 32 countries. SEPL is globally known for B2B brands like AshwaBoost®, CurcuBoost®, SPIRUproteen®, MORIMAXproteen®, ZingiNatPure®, BOSWpure®, WKB20K®, TetraBeauty® FENUTEIN®, and CENTpure®. The company has successfully filed 14 US DMFs with the US FDA for a range of natural extracts and Botanicals and has applied for 4 patents. SEPL serves companies in the segments of Nutraceuticals, Food Supplements, Pharma, Personal Care, Flavour and fragrance.

Media Contact:

Arun

If you object to the content of this press release, please notify [email protected]. We will get back to you and fix the situation within 24 hours.

A.K. Dwivedi Anemia Health homeopathy Indore Mohan Yadav pancytopenia sickle cell disease thalassemia

Dr. A.K. Dwivedi Presents Second Edition of ‘Homeopathy for Anemia’ to CM Mohan Yadav

Senior homoeopathic physician Dr. A.K. Dwivedi presents the second edition of his book ‘Homeopathy for Anemia’ to Madhya Pradesh Chief Minister Dr. Mohan Yadav during the Prominence Award-2026 ceremony. Indore: During the Prominence Award-2026 ceremony, senior homoeopathic physician Dr. A.K. Dwivedi presented a copy of the second edition of his book ‘Homeopathy for Anemia’ to […]

Read More
chandan healthcare diagnostics franchise network Health healthcare business NABH NABL NSE Emerge pathology radiology

Chandan Healthcare Scales Franchise Network to 500+ Franchises; Targets 1,000 Franchises by FY27-End

Lucknow (Uttar Pradesh) [India], September 23: Chandan Healthcare Limited (NSE – CHANDAN), – an integrated diagnostics company offering pathology and radiology services, has expanded its diagnostic franchise network to 568 franchises within a short span of six months, strengthening its last-mile presence and diagnostic collection network. The Company plans to scale the network to 1,000 […]

Read More
AI healthcare breast cancer screening c-met cdsco clinical trials fda Health lord’s mark medical device thermal imaging

Lord’s Mark Industries Gets Nod for Final Clinical Trials of AI Breast Cancer Screening Device

New Delhi [India], September 23: Lord’s Mark Industries Limited has informed the BSE that its Technical Committee has approved the final clinical trial stage for its AI-powered, radiation-free wearable breast cancer screening device, with trials planned across the USA, Great Britain and Europe. The disclosure was made under Regulation 30 of the SEBI Listing Obligations […]

Read More